Source: Tyson 2.0
  • HEXO Corp. (HEXO) has partnered with TYSON 2.0, Mike Tyson’s recently formed cannabis company
  • HEXO will produce TYSON 2.0’s full product line in Canada
  • TYSON 2.0 is a cannabis company formed with boxer Mike Tyson
  • HEXO is an award-winning licensed producer of innovative products for the global cannabis market
  • HEXO Corp. (HEXO) opened trading at C$0.265

HEXO Corp. (HEXO) has partnered with TYSON 2.0, Mike Tyson’s recently formed cannabis company.

Under the agreement, HEXO will produce TYSON 2.0’s products in Canada, including TYSON 2.0’s full range of flower, pre-rolls, edibles and vapes. The HEXO-produced lines will launch across Canada in fall 2022.

Charlie Bowman, CEO of HEXO Corp, commented on the partnership.

“We’re delighted that HEXO has been chosen as the exclusive Canadian producer for TYSON 2.0 brands. Our boutique cultivation capabilities and product offerings enable HEXO to elevate the consumer’s cannabis experience. With their broad product range from flower to straight edge pre-rolls to edibles, the TYSON 2.0 brand fits perfectly into HEXO’s market leading portfolio.”

Chad Bronstein, Co-founder, President and Chairman of TYSON 2.0, added,

“Our partnership with HEXO allows us to deliver TYSON 2.0’s vision of a premier cannabis experience to Canadians. TYSON 2.0 is dedicated to bringing innovative cannabis products to market, and HEXO’s strong reputation as the leader in quality standards made them the obvious choice in Canada.”

“We know that Canadians have been eager to try the TYSON 2.0 line and we’re excited to have signed this deal with HEXO, the ideal partner to produce the high-quality premium and affordable, cannabis flower, concentrates and consumables that we’re known for,” added Mike Tyson, Chief Brand Officer and Co-founder of TYSON 2.0.

TYSON 2.0 is a premier cannabis company formed with boxer and entrepreneur Mike Tyson.

HEXO is a licensed producer of innovative products for the global cannabis market.

HEXO Corp. (HEXO) opened trading at C$0.265.


More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.